Title : ABCB1 as a potential beneficial target of midostaurin in acute myeloid leukemia.

Pub. Date : 2022 Jun

PMID : 35462331






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 ABCB1 as a potential beneficial target of midostaurin in acute myeloid leukemia. midostaurin ATP binding cassette subfamily B member 1 Homo sapiens
2 Midostaurin, identified as an ABCB1 inhibitor, increased anthracycline accumulation in peripheral blood mononuclear cells (PBMC) of CD34+ AML patients and those not achieving CR. midostaurin ATP binding cassette subfamily B member 1 Homo sapiens
3 In line with these data, midostaurin potentiated proapoptotic processes in ABCB1-overexpressing leukemic cells when combined with anthracyclines. midostaurin ATP binding cassette subfamily B member 1 Homo sapiens
4 Overall, we highlight the therapeutic value of midostaurin as more than just a FLT3 inhibitor, suggesting its maximal therapeutic outcomes might be very sensitive to proper timing and well-optimized dosage schemes based upon patient"s characteristics, such as CD34 positivity and ABCB1 activity. midostaurin ATP binding cassette subfamily B member 1 Homo sapiens